glp-1 therapy for weight loss Medications: Everything You Need to Know GLP-1 therapy is changing the

One large observational study found that people who used GLP-1 medications had a significantly lower risk of developing Alzheimers disease

Maine Medical Center Institute for Research, Scarborough N Engl J Med 2026

1-3 They also decrease the release of glucagon, a hormone that raises blood sugar levels, as well as slowing the rate at which food is digested

Enhanced Energy Availability Phosphocreatine buffers ATP during resistance exercise, allowing for more repetitions and higher training volumes (critical stimuli for muscle protein synthesis)

Beneficiaries also can contact Express Scripts with coverage questions

8-12 weeks on followed by 4-8 weeks off is standard